A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms
The DOI matches its OpenAlex record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether the antidepressant, nortriptyline, is effective for treatment of depression, tinnitus-related disability, and tinnitus symptoms in patients with severe chronic tinnitus. DESIGN: A 12-week, double-blind, randomized controlled trial. SETTING: A university otolaryngology clinic. PATIENTS: Ninety-two subjects with severe chronic tinnitus: 38 with current major depression and 54 with depressive symptoms and significant tinnitus-related disability. INTERVENTION: Nortriptyline (maintained at 50 to 150 mg/mL for 6 weeks) or placebo. MAIN OUTCOME MEASURES: Hamilton Depression Rating Scale, Tinnitus Disability Measures, and Audiometric Measures. RESULTS: Nortriptyline was superior to placebo by multivariate analysis of covariance for depression (10.6 vs 14.3 final Hamilton Depression score), for tinnitus-related disability (1.8 vs 2.4 final MPI Tinnitus Interference), and tinnitus loudness (13.6 vs 20.0 dB final loudness match [in worst ear at tinnitus frequency]). When major depression and depressive symptoms groups were considered separately, nortriptyline was superior to placebo on these same measures but differences did not achieve statistical significance. CONCLUSIONS: The antidepressant nortriptyline decreases depression, functional disability, and tinnitus loudness associated with severe chronic tinnitus. What appears to be irreversible disability of otologic origin may, in part, be reversible disability of psychiatric origin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and safety of mianserin in the treatment of depression of women with cancer
Costa, D., Mogos, I., & Toma, T. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb08081.x · Cited by 202
Sullivan, M. D., Katon, W., Dobie, R., Sakai, C., Russo, J., & Harrop-Griffiths, J. (1988) · General Hospital Psychiatry · doi:10.1016/0163-8343(88)90037-0 · Cited by 189
Self-citation
Cited by
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465
Katon, W. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00273-7 · Cited by 1,223
Lenze, E. J., Rogers, J. C., Martire, L. M., Mulsant, B. H., Rollman, B. L., Dew, M. A., Schulz, R., & Reynolds, C. F. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200105000-00004 · Cited by 593
Comparative responsiveness of generic and specific quality-of-life instruments
Wiebe, S., Guyatt, G., Weaver, B., Matijevic, S., & Sidwell, C. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00537-1 · Cited by 573
Impact of major depression on chronic medical illness
Katon, W., & Ciechanowski, P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00313-6 · Cited by 485
Cognitive behavioural therapy for tinnitus
Martinez-Devesa, P., Perera, R., Theodoulou, M., & Waddell, A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005233.pub3 · Cited by 477
Lockwood, A. H., Salvi, R. J., & Burkard, R. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra013395 · Cited by 454
Comorbidity of migraine and psychiatric disorders—a national population-based study
Jette, N., Patten, S., Williams, J., Becker, W., & Wiebe, S. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00993.x · Cited by 363
“It is also important to understand whether an association exists between migraine and the various mental health disorder because treating depression in subjects with comorbid medical conditions may lead to improved symptom levels and functioning.(47,48) In this study, mental health disorders were found to be higher in…”
BackgroundKessler, R. C., Ormel, J., Demler, O., & Stang, P. E. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000100000.70011.bb · Cited by 330
Langguth, B., Landgrebe, M., Kleinjung, T., Sand, G. P., & Hajak, G. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.575178 · Cited by 321
“The tricyclic nortriptyline signifi cantly reduced depression scores, tinnitus disability scores, and tinnitus loudness relative to placebo (Sullivan et al., 1993).”
BackgroundDepression, fatigue, and functional disability in patients with chronic hepatitis C
Dwight, M. M., Kowdley, K. V., Russo, J. E., Ciechanowski, P. S., Larson, A. M., & Katon, W. J. (2000) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00155-0 · Cited by 258
Systematic review and meta-analyses of randomized controlled trials examining tinnitus management.
Hoare, D. J., Kowalkowski, V. L., Kang, S., & Hall, D. A. (2011) · The Laryngoscope · doi:10.1002/lary.21825 · Cited by 255
“Sullivan et al.50 compared nortriptyline (up to 100 mg at night, as tolerated) to placebo (lactose).”
BackgroundEll, K., Katon, W., Xie, B., Lee, P.-J., Kapetanovic, S., Guterman, J., & Chou, C.-P. (2010) · Diabetes Care · doi:10.2337/dc09-1711 · Cited by 223
Russo, J., Vitaliano, P. P., Brewer, D. D., & Katon, W. (1995) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.104.1.197 · Cited by 200
Tinnitus and its association with psychiatric disorders: Systematic review.
Pinto, P. C. L., Marcelos, C. M., Mezzasalma, M. A., Osterne, F. J. V., de Melo Tavares de Lima, M. A., & Nardi, A. E. (2014) · The Journal of Laryngology & Otology · doi:10.1017/s0022215114001030 · Cited by 132
Therapeutic approaches to the treatment of tinnitus
Langguth, B., Elgoyhen, A. B., & Cederroth, C. R. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021556 · Cited by 129
Sound therapy (masking) in the management of tinnitus in adults
Hobson, J., Chisholm, E., & El Refaie, A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006371.pub2 · Cited by 59
Metadata
- Authors
- Sullivan, M. D.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1993-10-11
- Volume
- 153
- Issue
- 19
- Pages
- 2251-2259
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W4247457843
- Cited by
- 191
- References
- 2
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.